31 filings
8-K
EIDX
Eidos Therapeutics, Inc.
26 Jan 21
Entry into a Material Definitive Agreement
8:46am
8-K
EIDX
Eidos Therapeutics, Inc.
20 Jan 21
Submission of Matters to a Vote of Security Holders
4:23pm
8-K
EIDX
Eidos Therapeutics, Inc.
12 Jan 21
Other Events
7:31am
8-K
EIDX
Eidos Therapeutics, Inc.
29 Oct 20
Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
4:30pm
8-K
EIDX
Eidos Therapeutics, Inc.
6 Oct 20
Entry into a Material Definitive Agreement
9:35pm
8-K
dxabq8yyd8zv
5 Oct 20
Bridgebio Pharma and Eidos Therapeutics Announce Merger Agreement
4:06pm
8-K
5a6y cr12r
29 Sep 20
Regulation FD Disclosure
7:15am
8-K
re7xjxm
7 Aug 20
Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors
4:56pm
8-K
4ctk0ynr5amekb
6 Aug 20
Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business Update
4:33pm
8-K
7i4koyauo1ep
1 Jun 20
Departure of Directors or Certain Officers
4:05pm
8-K
otx9r4paozj73he4rc6
8 May 20
Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update
4:30pm
8-K
u7ec2w
24 Mar 20
Other Events
6:06am
8-K
q7o820cim4kosli9act
26 Feb 20
Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update
4:30pm
8-K
6lyik7aodr 0oo7
7 Jan 20
Departure of Directors or Certain Officers
4:48pm
8-K
aoscxymfeursp4
17 Dec 19
Departure of Directors or Certain Officers
4:03pm
8-K
hok471a4ziony034p0z
18 Nov 19
Entry into a Material Definitive Agreement
8:01am
8-K
xmf4xse a12
31 Oct 19
Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business Update
4:30pm
8-K
m4117sww
13 Sep 19
Eidos Therapeutics Special Committee Rejects Proposal from BridgeBio Pharma to Acquire Shares
4:05pm
8-K
rp07bxj lkr13yyg45hf
11 Sep 19
Entry into a Material Definitive Agreement
4:36pm
8-K
vdeyu7q1sw60ci7
12 Aug 19
Eidos Therapeutics Confirms Receipt ofNon-Binding Proposal from BridgeBio Pharma to Acquire Shares
4:27pm